Status:
UNKNOWN
Frozen Embryo Transfer With GnRH-antagonist Trial
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Oxford Fertility Limited, United Kingdom
Conditions:
Infertility
Eligibility:
FEMALE
18-42 years
Phase:
PHASE4
Brief Summary
The fertility treatment in vitro fertilisation (IVF), sometimes including intra-cytoplasmic sperm injection (ICSI), involves the creation of embryos in a laboratory. These embryos are then transferred...
Eligibility Criteria
Inclusion
- Willing and able to give informed consent for participation in the study.
- Planning to undergo medicated FET
- Blastocyst embryo in storage available for transfer
Exclusion
- Previously randomised into the trial.
- A history of 3 or more consecutive implantation failures (after fresh or frozen embryo transfer).
- A history of recurrent miscarriage (3 or more consecutive miscarriages).
- Contraindication to the use of medications for FET cycle.
- Biopsied embryos.
- Donor embryos or eggs (use of donor sperm is not excluded).
Key Trial Info
Start Date :
December 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03763786
Start Date
December 13 2018
End Date
January 1 2021
Last Update
April 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Fertility
Oxford, United Kingdom, OX4 2HW